JP2022511477A5 - - Google Patents

Info

Publication number
JP2022511477A5
JP2022511477A5 JP2021531523A JP2021531523A JP2022511477A5 JP 2022511477 A5 JP2022511477 A5 JP 2022511477A5 JP 2021531523 A JP2021531523 A JP 2021531523A JP 2021531523 A JP2021531523 A JP 2021531523A JP 2022511477 A5 JP2022511477 A5 JP 2022511477A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
pharmaceutically acceptable
solvate
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021531523A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022511477A (ja
JP7546299B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063921 external-priority patent/WO2020117635A1/en
Publication of JP2022511477A publication Critical patent/JP2022511477A/ja
Publication of JP2022511477A5 publication Critical patent/JP2022511477A5/ja
Application granted granted Critical
Publication of JP7546299B2 publication Critical patent/JP7546299B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021531523A 2018-12-03 2019-12-02 Ire1小分子阻害物質 Active JP7546299B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862774794P 2018-12-03 2018-12-03
US62/774,794 2018-12-03
PCT/US2019/063921 WO2020117635A1 (en) 2018-12-03 2019-12-02 Ire1 small molecule inhibitors

Publications (3)

Publication Number Publication Date
JP2022511477A JP2022511477A (ja) 2022-01-31
JP2022511477A5 true JP2022511477A5 (enExample) 2022-12-02
JP7546299B2 JP7546299B2 (ja) 2024-09-06

Family

ID=69024615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021531523A Active JP7546299B2 (ja) 2018-12-03 2019-12-02 Ire1小分子阻害物質

Country Status (8)

Country Link
US (1) US12071426B2 (enExample)
EP (1) EP3891137B1 (enExample)
JP (1) JP7546299B2 (enExample)
AU (1) AU2019393754A1 (enExample)
CA (1) CA3121755A1 (enExample)
IL (1) IL283433A (enExample)
SG (1) SG11202105690TA (enExample)
WO (1) WO2020117635A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI831829B (zh) 2018-09-12 2024-02-11 美商建南德克公司 苯氧基-吡啶基-嘧啶化合物及使用方法
US12071426B2 (en) 2018-12-03 2024-08-27 Cornell University IRE1 small molecule inhibitors
WO2020142612A1 (en) 2019-01-03 2020-07-09 Genentech, Inc. Pyrido-pyrimidinone and pteridinone compounds as inhibitors of endoribonuclease inositol requiring enzyme i (ire i alpha) for the treatment of cancer diseases.
AR118119A1 (es) * 2019-02-18 2021-09-22 Genentech Inc Compuestos de pirido-pirimidinilo y métodos de uso
WO2020232403A1 (en) * 2019-05-15 2020-11-19 Cornell University Treatment of fibrosis with ire1 small molecule inhibitors
EP3983400B1 (en) * 2019-06-11 2025-05-28 Genentech, Inc. Quinazolinyl compounds and methods of use
US11840523B2 (en) * 2020-11-13 2023-12-12 The Regents Of The University Of California IRE1α inhibitors and uses thereof
IL302807A (en) 2020-11-18 2023-07-01 Deciphera Pharmaceuticals Llc Gcn2 and perk kinase inhibitors and methods of use thereof
PE20250609A1 (es) 2021-12-03 2025-02-26 Deciphera Pharmaceuticals Llc Inhibidores de gcn2 y perk quinasa y metodos de uso de los mismos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8664230B2 (en) 2011-03-17 2014-03-04 The Asan Foundation Pyridopyrimidine derivatives and use thereof
EP3548476A4 (en) * 2016-12-02 2020-05-20 Quentis Therapeutics, Inc. SMALL MOLECULAR IRE1 INHIBITORS
CN108239074B (zh) 2016-12-26 2021-07-06 中国医学科学院药物研究所 喹唑啉类化合物及其制备方法、用途和药物组合物
AR111281A1 (es) 2017-03-17 2019-06-26 Genentech Inc Compuestos de pirimidinil-piridiloxi-naftil y métodos para tratar enfermedades y trastornos relacionados con ire1
JP7126084B2 (ja) * 2017-06-01 2022-08-26 コーネル ユニバーシティー Ire1小分子阻害薬
WO2019094641A1 (en) * 2017-11-10 2019-05-16 Quentis Therapeutics, Inc. Ire1 small molecule inhibitors
US12071426B2 (en) 2018-12-03 2024-08-27 Cornell University IRE1 small molecule inhibitors

Similar Documents

Publication Publication Date Title
JP2022511477A5 (enExample)
JP2021502387A5 (enExample)
JP2024520481A5 (enExample)
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
CN114430739A (zh) Egfr抑制剂、组合物及其制备方法
JP2011509309A5 (enExample)
JP2024156774A5 (enExample)
JP2022520061A5 (enExample)
JP2006505543A5 (enExample)
JP2014503574A5 (enExample)
JP2020522520A5 (enExample)
JP2004517087A5 (enExample)
JP2005523922A5 (enExample)
JP2012508252A5 (enExample)
JP2011219498A5 (enExample)
JP2008510828A5 (enExample)
JP2021535112A5 (enExample)
JP2004517049A5 (enExample)
JP2017532360A5 (enExample)
JP2022549222A5 (enExample)
JP2014528464A5 (enExample)
JP2007520440A5 (enExample)
JP2020128426A5 (enExample)
JP2010527985A5 (enExample)
JP2011509302A5 (enExample)